NASDAQ:GYRO Gyrodyne (GYRO) Stock Price, News & Analysis $7.51 -0.14 (-1.78%) Closing price 05/22/2026 03:58 PM EasternExtended Trading$7.54 +0.03 (+0.35%) As of 05/22/2026 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Gyrodyne Stock (NASDAQ:GYRO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Gyrodyne alerts:Sign Up Key Stats Today's Range$7.30▼$7.9650-Day Range$6.89▼$8.9652-Week Range$6.70▼$12.00Volume3,109 shsAverage Volume534 shsMarket Capitalization$16.53 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Gyrodyne Company of America, Inc. is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations. The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island. This portfolio features a diversified mix of multi-tenant buildings that house outpatient services, rehabilitation centers and specialty laboratories. Gyrodyne’s strategic approach involves acquiring under-utilized or newly developed properties, investing in targeted capital improvements, and securing long-term leases with creditworthy tenants. Through hands-on property management and an emphasis on tenant retention, the firm aims to enhance asset value and maintain a resilient revenue base. Originally founded in 1959 and initially engaged in rotorcraft design and manufacturing, Gyrodyne transitioned to a real estate-focused business in the late 1980s. Over the decades, the company has built deep ties to the greater Long Island region, leveraging local market knowledge and zoning expertise to support its development initiatives. Led by an experienced management team and overseen by a board of directors with backgrounds in real estate and healthcare industries, Gyrodyne continues to pursue opportunities that align with its mission of delivering high-quality, medically oriented real estate solutions to its tenant community.AI Generated. May Contain Errors. Read More Receive GYRO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Gyrodyne and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GYRO Stock News HeadlinesGyrodyne (NASDAQ:GYRO) Stock Price Crosses Below Two Hundred Day Moving Average - Here's WhyMay 19, 2026 | americanbankingnews.comGyrodyne amends Flowerfield property sale agreement with B2K SmithtownJanuary 14, 2026 | investing.comJune 4: The day smart money moves (not June 12)Everyone is watching June 12 - the SpaceX listing date. The real deadline is June 4, when Goldman Sachs, Morgan Stanley, and the largest funds begin presenting SpaceX's S-1 to clients. Buried in that filing is a small, publicly traded company that builds critical power infrastructure Musk's Colossus can't operate without. Right now it trades like a sleepy industrial stock. Dylan Jovine has the ticker and is releasing it before the roadshow begins.May 24 at 1:00 AM | Behind the Markets (Ad)Gyrodyne enters agreement with Star Equity FundOctober 17, 2025 | msn.comGyrodyne Announces Agreement with Star Equity FundOctober 17, 2025 | globenewswire.comGyrodyne trading halted, news pendingAugust 6, 2025 | msn.comGYRODYNE, LLC ANNOUNCES AGREEMENT TO SELL 49-ACRE PARCEL IN SMITHTOWN, NEW YORK AS PART OF STRATEGIC LIQUIDATION PLANAugust 4, 2025 | globenewswire.comHere's How Much Horsepower Boeing's T50 Engines Can HaveJuly 13, 2025 | msn.comSee More Headlines GYRO Stock Analysis - Frequently Asked Questions How have GYRO shares performed this year? Gyrodyne 's stock was trading at $9.11 at the beginning of the year. Since then, GYRO shares have decreased by 17.5% and is now trading at $7.5140. How do I buy shares of Gyrodyne ? Shares of GYRO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Gyrodyne own? Based on aggregate information from My MarketBeat watchlists, some other companies that Gyrodyne investors own include Meta Platforms (META), Astrotech (ASTC), Athersys (ATHX) and Company Calendar Today5/24/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 GYRO's financial health is in the Red zone, according to TradeSmith. GYRO has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorFinance Industry REAL ESTATE OPS Sub-IndustryDiversified REITs Current SymbolNASDAQ:GYRO CIK1589061 Webwww.gyrodyne.com Phone(631) 584-5400Fax631-584-7075Employees6Year Founded1946Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares2,200,000Free Float1,933,000Market Cap$16.53 million OptionableNot Optionable Beta0.52 Social Links The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NASDAQ:GYRO) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredA 25,000% opportunityAngel investor Jason Calacanis - who made a fortune on an early Uber stake - says Elon Musk's latest project c...The Oxford Club | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredOne coin wired into Elon's visionSpaceX just filed its IPO paperwork. And buried inside that filing was something that should change how every ...Crypto 101 Media | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gyrodyne , LLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Gyrodyne With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
